The estimated Net Worth of Llc Fmr is at least $155 Million dollars as of 13 February 2024. Llc Fmr owns over 901,565 units of Toast stock worth over $30,887,775 and over the last 14 years Llc sold TOST stock worth over $124,511,219.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Llc Fmr TOST stock SEC Form 4 insiders trading
Llc has made over 88 trades of the Toast stock since 2012, according to the Form 4 filled with the SEC. Most recently Llc sold 901,565 units of TOST stock worth $27,542,811 on 13 February 2024.
The largest trade Llc's ever made was selling 2,045,510 units of Toast stock on 5 February 2021 worth over $14,277,660. On average, Llc trades about 91,072 units every 34 days since 2010. As of 13 February 2024 Llc still owns at least 1,235,511 units of Toast stock.
You can see the complete history of Llc Fmr stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Llc Fmr's mailing address?
Llc's mailing address filed with the SEC is 245 Summer St, Boston, MA 02210, USA.
Insiders trading at Toast
Over the last 3 years, insiders at Toast have traded over $683,900,700 worth of Toast stock and bought 1,995,512 units worth $52,290,219 . The most active insiders traders include Venture Partners Ix L.P.Bes..., Investment Dining Group, Ll... und Llc Fmr. On average, Toast executives and independent directors trade stock every 4 days with the average trade being worth of $4,024,650. The most recent stock trade was executed by Christopher P Comparato on 20 August 2024, trading 100,000 units of TOST stock currently worth $152,000.
What does Toast's logo look like?
Complete history of Llc Fmr stock trades at Aclaris Therapeutics Inc, Blueprint Medicines Corp, Coherus Biosciences Inc, Insmed Inc, Ironwood Pharmaceuticals Inc, Proteostasis Therapeutics Inc, Regenxbio Inc, Tetraphase Pharmaceuticals, Ultragenyx Pharmaceutical, ViewRay, Generac Inc, Mersana Therapeutics Inc, Denali Therapeutics Inc, Menlo Therapeutics, Unum Therapeutics, Surface Oncology Inc, Orchard Therapeutics plc, Precision BioSciences, Beam Therapeutics und Toast
Toast executives and stock owners
Toast executives and other stock owners filed with the SEC include:
-
Jennifer DiRico,
Sr. VP of Fin. -
Christopher P. Comparato,
CEO & Director -
Brian R. Elworthy,
Gen. Counsel -
Stephen Fredette,
Co-Founder, Co-Pres & Director -
Alice Kousoum Lopatto,
VP of Investor Relations -
Anisha Vaswani,
Chief Information Officer -
James Michael Matlock,
Chief Accounting Officer & Principal Accounting Officer -
Elena Gomez,
Chief Financial Officer -
Jonathan Grimm,
CTO & Co-Founder -
Aman Narang,
Co-Founder, Co-Pres, COO & Director -
Capital Management, L.P.Hmi...,
-
Jonathan Grimm,
Chief Technology Officer -
Aman Narang,
CEO -
Susan Chapman Hughes,
Director -
Mark J Hawkins,
Director -
Deval L Patrick,
Director -
Paul D Bell,
Director -
Venture Partners Ix L.P.Bes...,
-
Investment Dining Group, Ll...,
-
Richard Kent Bennett,
-
Elena Gomez,
Chief Financial Officer -
Brian R Elworthy,
General Counsel -
Christopher P Comparato,
Director -
James Michael Matlock,
Principal Accounting Officer -
Crossover Management X, Ltd...,
-
Hilarie A. Koplow,
Director -
Llc Fmr,
-
Stephen Fredette,
President -
Investment Dining Group, Ll...,
10% owner -
David Yuan,
Director -
Venture Partners Ix L.P.Bes...,
-
Jonathan Vassil,
Chief Revenue Officer